Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinib

Eur J Cancer. 2022 May:166:38-40. doi: 10.1016/j.ejca.2022.02.007. Epub 2022 Mar 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acrylamides
  • Aniline Compounds / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Circulating Tumor DNA* / genetics
  • ErbB Receptors / genetics
  • Exons
  • Genotype
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use
  • Real-Time Polymerase Chain Reaction

Substances

  • Acrylamides
  • Aniline Compounds
  • Circulating Tumor DNA
  • Protein Kinase Inhibitors
  • osimertinib
  • EGFR protein, human
  • ErbB Receptors